SPAC Podcast: Alliance Entertainment & Adara Acquisition

by | Aug 12, 2022

Bruce Ogilvie and Jeff Walker discuss Alliance Entertainment going public via Adara Acquisition Corp. (ADRA)

CDs, DVDs, & Vinyl are Still Big Money with Alliance Entertainment’s Bruce Ogilvie & Jeff Walker

Bruce Ogilvie (Chairman) and Jeff Walker (CEO) both have long history in the entertainment distribution industry. Their current company, Alliance Entertainment, has struck a deal to go public via Adara Acquisition Corp. (ADRA). Alliance is a distributor, buying physical entertainment goods from content providers (music companies, gaming companies etc.), and selling to retailers, e-commerce, and even a little D2C. Their aim is to be a one-stop-shop for all things entertainment.

Source: Alliance investor presentation

While obviously media and entertainment is going thru a digital transformation, it should not be lost that physical goods, including CDs, DVDs, and vinyl, still generate billions of dollars of sales per year. In fact, Alliance’s vinyl sales alone are a $300M business year and growing. It may come as a surprise to many, but physical assets continue represent a real business. While the growth of current products might not be hockey-stick, Alliance wants to continue to grab market share and expand to new areas.

As for use of proceeds and timing? Alliance has a DNA of being acquisitive (including gaming company COKeM last year) and believes that having a public currency will be advantageous for their M&A plans going forward. Fun listen with Jeff and Bruce.

See their investor presentation here

On the podcast Bruce and Jeff discuss:

  • Career histories and experience in the consumer arena
  • Overview of Alliance Entertainment business
  • What does the business look like in a world where physical products are becoming increasingly digitized?
  • Growth plans for Alliance
  • Revenue breakdown and growth attribution
  • M&A plan and history
  • Why now for SPAC and to become a public company
  • Wrap-up

About Bruce and Jeff

About Adara Acquistion Corp. (ADRA)

Adara Acquisition Corp. (ADRA) is led by Tom Finke, former CEO of Barings, and Martin Sumichrast, Chairman of cbdMD. Adara was targeting a company in the consumer products sector, and raised a $115M IPO in February 2021.

<a href="" target="_self">David Drapkin</a>

David Drapkin

Spent his formative years at Goldman Sachs and now embraces the start-up life in NYC. A long suffering Oakland (Las Vegas) Raiders fan and graduate of the Wharton School at the University of Pennsylvania. Semi-professional go-kart racer waiting for his shot.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

SPAC Market Review – January 2022

January saw the SPAC market fall quickly alongside the broader market as a revolt against “spec tech” and overall sentiment drove it lower.

SPAC Market Review – December 2021

2021 is drawing to a close and what a year it was for SPACs. In our December market update we take a look at the last month of the year and give our latest thoughts on the market, including: record IPO issuance and SPAC supply; aging SPACs and outlook for terminations; and the merger market including its financing evolution

SPAC Research & Analysis

SPAC Daily: Tuesday 9/14

Maxpro Acquisition (JMAC) penned the lone SPAC DA of the day, plus the rest of today’s news in the market.

SPAC Daily: A Merger Monday

4 new SPAC deals to get the week started, a new SPAC for dMY plus of the rest of the day’s SPAC market news.

Know Who Drives Return Podcast

FOXO Technologies CEO Jon Sabes Is About to Disrupt the Insurance Industry

Boardroom Alpha talks to Jon Sabes, CEO of FOXO Technologies, which announced a SPAC merger with sponsor Delwinds Insurance Acquisition Corp. (DWIN). Sabes explains how epigenetic biomarkers can change the game for life insurance companies and tell us more about health and wellness than ever before.


The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.